Company Info
Profound Medical Inc. is a Canadian-based medical technology company that was established in 2008. The company specializes in developing innovative therapies for the treatment of cancer and other medical conditions using focused ultrasound, magnetic resonance imaging (MRI), and thermal ablation technology. Profound Medical aims to provide non-invasive, precise treatment options for patients, offering alternatives to traditional surgical procedures. The company’s flagship product, TULSA-PRO®, is a cutting-edge device for prostate tissue ablation, combining the advantages of MRI for accurate targeting and high-intensity focused ultrasound for precise tissue destruction. Profound Medical’s commitment to advancing medical treatments and improving patient outcomes has made it a recognized player in the healthcare sector. The company's headquarters is located in Mississauga, Ontario, Canada. Its shares are traded on the Toronto Stock Exchange under the ticker symbol "PRN," reflecting its ongoing growth and innovation within the medical field.